Takeda Pharmaceuticals America Articles
Add-on benefits of Actos shown in study
20 June 2005
Japan stock market week to June 10
20 June 2005
B-M Squibb/Merck & Co's Pargluva: good PhI/II
20 June 2005
Japan stock market week to May 30
6 June 2005
Takeda breaks ground on new US site
16 May 2005
Sankyo and Daiichi prepare to merge?
28 February 2005
CORRECTION: Takeda's ramelteon is not FDA approved
10 January 2005
Takeda's Actoplus Met filed in USA
8 November 2004
Takeda No 1 in "corporate excellence" in Japan
4 October 2004
New president of TAP Pharma named
6 September 2004
Takeda sets up North America diabetes research grant
23 June 2003
Takeda anticipates 10th successive record profit
20 May 2002
TAP gets fast-track review of Prevacid for children
22 April 2002
Tokyo pharma stocks - week to February 18
25 February 2002
Aventis gets OK for Actonel in Japan
28 January 2002
Takeda/Lilly underwrite US Rx cost/benefit report
19 October 2001
Japan pharma stock market - week to October 15
17 October 2001
Takeda North America appointments
20 September 2001
Stock Commentary Tokyo
11 May 2000
Takeda Entering New Product Cycle
21 September 1998
Takeda Pharma Sets Up Swiss Subsidiary
11 September 1998
New Takeda Subsidiary
23 January 1995
TAKEDA NEW SUSTAIN RELEASE DEVELOPMENT
3 August 1992
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
